Ewing's sarcoma as a second malignant neoplasm in a child previously treated for Wilms' tumor

J Pediatr Hematol Oncol. 1995 Feb;17(1):76-80. doi: 10.1097/00043426-199502000-00014.

Abstract

Purpose: Second malignant neoplasms (SMNs) are a rare occurrence after the successful treatment of childhood cancer. For survivors of Wilms' tumor, the 10-year cumulative risk of developing an SMN has been estimated to be 1%. Bone sarcomas arising within the radiation field are a common occurrence, yet Ewing's sarcoma has been rarely reported as an SMN.

Patients and methods: A 10-year-old girl presented with dyspnea 5 years after the diagnosis of stage III favorable histology Wilms' tumor and was found to have a right intrathoracic mass arising from the eighth and ninth ribs. The mass was located at the edge of the previous radiation field.

Results: Tumor cytogenetics and immunocytochemistry were helpful in establishing the diagnosis of Ewing's sarcoma. Treatment included combination chemotherapy, with hematopoietic growth factor support, and excluded anthracyclines and radiotherapy. More than 1 year after the diagnosis of Ewing's sarcoma, the patient has completed therapy with no evidence of disease.

Conclusions: This is the first report to our knowledge of Ewing's sarcoma arising in the irradiation field of a patient treated previously for Wilms' tumor.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Child
  • Chromosome Aberrations / pathology
  • Chromosome Disorders
  • Female
  • Genes, p53
  • Humans
  • Karyotyping
  • Neoplasms, Second Primary*
  • Sarcoma, Ewing / complications*
  • Sarcoma, Ewing / genetics
  • Wilms Tumor / complications*